Radiology Business October 20, 2023
Marty Stempniak

Radiology has experienced the steadiest increase of artificial intelligence/machine learning-enabled device submissions of any specialty, the U.S. Food and Drug Administration reported Thursday.

Through the end of July, 79% of all AI products authorized by the agency in 2023 are in radiology (85 products), followed by 9% in cardiovascular care (10), 5% in neurology (5), 4% in gastroenterology/urology (4) and 2% in anesthesiology (2).

“Interest in medical devices incorporating AI/ML functionality has increased in recent years and even more so in recent months due to the development of large language models,” the agency said Oct. 19, pointing to products such as ChatGPT, Llama, Claude and PaLM.

Based on projected volume in 2023, the increase of AI-powered devices is expected to...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: AI (Artificial Intelligence), FDA, Govt Agencies, Medical Devices, Provider, Radiology, Technology
Related Articles:
Your Earphones And Headphones As Health And Medical Devices
Medtronic, Tempus testing AI to find potential TAVR patients
AI Robot Scanner as Good as Rheumatologists at Assessing RA
Regulatory Hurdles and Ethical Concerns Beset FDA Oversight of AI/ML Devices
From SpaceTech to MedTech: What medical device engineering teams can learn from aerospace

Share This Article